Literature DB >> 9413425

Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group.

E M de Kleijn1, J P Vandenbroucke, J W van der Meer.   

Abstract

Internal medicine wards in all 8 university hospitals in the Netherlands participated in this prospective study of fever of unknown origin (FUO) from January 1992 until January 1994 in order to update information on the spectrum of diseases causing FUO. We used fixed epidemiologic entry criteria to achieve completeness of enrollment and to avoid unintended selection bias. After entry, immunocompetent patients were included using criteria for FUO according to Petersdorf and Beeson (30). A standardized diagnostic protocol was used, and potentially diagnostic clues (PDCs) and their use in the diagnostic process were prospectively registered. Thus, the criteria of classic FUO have been adjusted to modern times: immunocompromised patients are excluded, and the time-criterion "1 week in hospital without a diagnosis" has been replaced by a quality-criterion stating that certain investigations must be performed as a minimum, and PDCs must be followed adequately for at least 1 week, without a diagnosis being reached. A total of 167 immunocompetent patients with FUO were thus retrieved, of whom 43 (25.7%) had infections, 21 (12.6%) had neoplasms, and 40 (24.0%) had noninfectious inflammatory diseases. No diagnosis was made in 50 patients (29.9%), 37 of whom recovered spontaneously. This study confirms the changing spectrum of diseases causing FUO. Indeed, as shown by another recent study, the group of patients with FUO in whom no diagnosis can be made is expanding, and mostly it concerns self-limiting or benign fevers. Others have suggested that this trend is not really occurring (29). We did not place patients with diseases of unknown origin in the "nondiagnosis" group, and indeed made presumptive diagnoses when necessary. Nevertheless, this category of undiagnosed fevers is increasing. We believe that the higher percentage of undiagnosed cases can be attributed to the greater use of advanced diagnostic techniques attendant on an increased number of self-limited illnesses in patients meeting criteria for FUO. Because of ongoing development in diagnostic techniques and the prospective influence on the spectrum of diseases causing FUO, studies should be performed regularly to update information on this subject. Because the number of outpatient evaluations for FUO is expected to increase, patients seen on an outpatient basis should be included in future studies. To avoid unwanted selection bias, fixed epidemiologic entry criteria should be used to ensure completeness of enrollment. To shorten the period of collecting data, multicentric studies can be done using standardized diagnostic protocols. In patients with recurrent fever or fever lasting longer than 6 months, the chance of reaching a diagnosis is significantly lower, and especially in this group one should exercise the greatest caution to avoid abundant and extensive diagnostic procedures. The diagnostic process in patients with FUO remains an intriguing problem in medicine. Recent microbiologic techniques may be useful as an approach to the relatively large proportion of patients in whom we now fail to make a diagnosis.

Entities:  

Mesh:

Year:  1997        PMID: 9413425     DOI: 10.1097/00005792-199711000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  54 in total

1.  Rheumatic diseases as causes of fever of unknown origin: an update of classic data.

Authors:  Mehmet Akif Oztürk; Sedat Kiraz; Ihsan Ertenli; Omrüm Uzun; Meral Calgüneri; Serhat Unal
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

2.  Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.

Authors:  Chantal P Bleeker-Rovers; Elisabeth M H A de Kleijn; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-10       Impact factor: 9.236

3.  Cervico-mediastinal tuberculous lymphadenitis presenting as prolonged fever of unknown origin.

Authors:  Yasar Bayindir; Alper Sevinc; Kivanc Serefhanoglu; Ayse But
Journal:  J Natl Med Assoc       Date:  2004-05       Impact factor: 1.798

4.  Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.

Authors:  Chantal P Bleeker-Rovers; Frans H M Corstens; Jos W M Van Der Meer; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

5.  Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis.

Authors:  A D Wagner; J Andresen; E Raum; J Lotz; H Zeidler; J G Kuipers; M C Jendro
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

Review 6.  [Fever of unknown origin in gastroenterology].

Authors:  T Schneider; S Daum; C Loddenkemper; M Zeitz
Journal:  Internist (Berl)       Date:  2009-06       Impact factor: 0.743

7.  A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Aart H Mudde; Anton S M Dofferhoff; Lioe-Fee de Geus-Oei; Anton J Rijnders; Paul F M Krabbe; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-14       Impact factor: 9.236

Review 8.  Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET.

Authors:  Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2011-05-24

9.  Futility of Performing Bone Marrow Cultures in Pyrexia of Unknown Origin.

Authors:  Anupama Arya; Rahul Naithani
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-19       Impact factor: 0.900

10.  The diagnostic value of 18F-FDG PET/CT in identifying the causes of fever of unknown origin.

Authors:  Wan Zhu; Wenxia Cao; Xuting Zheng; Xuena Li; Yaming Li; Baiyi Chen; Jingping Zhang
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.